These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38295234)

  • 21. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
    Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F
    BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
    Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review.
    Lunardi M; Al-Habbaa A; Abdelshafy M; Davey MG; Elkoumy A; Ganly S; Elzomor H; Cawley C; Sharif F; Crowley J; Kerin M; Wijns W; Lowery A; Soliman O
    BMC Cancer; 2022 Apr; 22(1):396. PubMed ID: 35413811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
    Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
    World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression.
    Gusterson BA
    Eur J Cancer; 1992; 28(1):263-7. PubMed ID: 1348953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply to Letter to the Editor: "Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?".
    Dindaş F; Güngör H; Ekici M; Akokay P; Erhan F; Doğduş M; Yılmaz MB
    Anatol J Cardiol; 2022 Apr; 26(4):344. PubMed ID: 35435851
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study.
    Gunaldi M; Duman BB; Afsar CU; Paydas S; Erkisi M; Kara IO; Sahin B
    J Oncol Pharm Pract; 2016 Apr; 22(2):242-7. PubMed ID: 25567518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter to the Editor: Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases.
    Matharu GS; Whitehouse MR
    Clin Orthop Relat Res; 2018 Dec; 476(12):2459-2461. PubMed ID: 30427316
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical benefit of epidermal growth factor receptor and human epidermal growth factor receptor 2 targeted agents adding to endocrine therapy in hormone receptor-positive breast cancer.
    Li H; Zhai Q; Yu B
    J Cancer Res Ther; 2018; 14(Supplement):S218-S223. PubMed ID: 29578177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer.
    Ben Kridis W; Sghaier S; Charfeddine S; Toumi N; Daoud J; Kammoun S; Khanfir A
    Am J Clin Oncol; 2020 Jul; 43(7):510-516. PubMed ID: 32304433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.
    Wu Q; Bai B; Tian C; Li D; Yu H; Song B; Li B; Chu X
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):511-524. PubMed ID: 33847848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trastuzumab cardiotoxicity: from clinical trials to experimental studies.
    Nemeth BT; Varga ZV; Wu WJ; Pacher P
    Br J Pharmacol; 2017 Nov; 174(21):3727-3748. PubMed ID: 27714776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients.
    He X; Dai X; Ji J; Liu H; Shi G; Yeung SJ
    Clin Breast Cancer; 2022 Jan; 22(1):e80-e90. PubMed ID: 34312098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
    Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
    Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
    Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
    J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.
    Baulida J; Kraus MH; Alimandi M; Di Fiore PP; Carpenter G
    J Biol Chem; 1996 Mar; 271(9):5251-7. PubMed ID: 8617810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu.
    Worthylake R; Wiley HS
    J Biol Chem; 1997 Mar; 272(13):8594-601. PubMed ID: 9079690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer.
    Bonzano E; Guenzi M; Corvò R
    In Vivo; 2018; 32(4):879-882. PubMed ID: 29936473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects.
    Polosa R; Puddicombe SM; Krishna MT; Tuck AB; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2002 Jan; 109(1):75-81. PubMed ID: 11799369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts.
    Udagawa C; Kuah S; Shimoi T; Kato K; Yoshida T; Nakano MH; Shimo A; Kojima Y; Yoshie R; Tsugawa K; Mushiroda T; Tan EY; Zembutsu H
    Biol Pharm Bull; 2022; 45(8):1198-1202. PubMed ID: 35908902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.